Disruption of SLFN11 Deficiency–Induced CCL2 Signaling and Macrophage M2 Polarization Potentiates Anti–PD-1 Therapy Efficacy in Hepatocellular CarcinomaChenhao Zhou, Ning Ren|Gastroenterology|2023Cited by 109
Anlotinib Reverses Multidrug Resistance (MDR) in Osteosarcoma by Inhibiting P-Glycoprotein (PGP1) Function In Vitro and In VivoGangyang Wang, Chenhao Zhou|Frontiers in Pharmacology|2022Cited by 23